Biochemical Characterization of Purified, Human Recombinant Lys304→Glu Medium‐Chain Acyl‐Coa Dehydrogenase Containing the Common Disease‐Causing Mutation and Comparison with the Normal Enzyme
Open Access
- 1 June 1997
- journal article
- research article
- Published by Wiley in European Journal of Biochemistry
- Vol. 246 (2) , 548-556
- https://doi.org/10.1111/j.1432-1033.1997.00548.x
Abstract
Recombinant, normal human medium‐chain acyl‐CoA dehydrogenase (MCADH) and the common, human disease‐causing K304E mutant ([Glu304]MCADH) protein were expressed in Escherichia coli using an optimized system, and the enzymes were purified to apparent homogeneity. The crucial factor leading to the production of active [Glu304]MCADH protein is the expression in E. coli cells at reduced temperature (28 °C). Expression in the same system at 37 °C results in very low amounts of active mutant protein. Several catalytic and physicochemical parameters of these two proteins have been determined and were compared to those of purified pig kidney MCADH. Although [Glu304]MCADH has approximately the same rate of substrate reduction with dodecanoyl‐CoA and the same Vmax as human MCADH with the best substrate for the latter, octanoyl‐CoA, the Km in the mutant MCADH is fourfold higher, which generates a correspondingly lower catalytic efficiency. Importantly, Vmax obtained using the natural acceptor, electron transfer flavoprotein, is only a third that for human MCADH. The Vmax/Km versus chain‐length profile of the mutant shows a maximum with dodecanoyl‐CoA which differs markedly from that of human MCADH, which has maximal efficiency with octanoyl‐CoA. The substrate specificity of the mutant is broader with a less pronounced activity peak resembling long‐chain acyl‐CoA dehydrogenase. The purified mutant enzyme exhibits a reduced thermal stability compared to human wild‐type MCADH. The major difference between the two proteins expressed in E. coli is the more pronounced lability of the K304E mutant in crude extracts, which suggests a higher susceptibility to attack by endogenous proteases. Differences between tetrameric [Glu304]MCADH which survives the first step(s) of purification and corresponding MCADH are minor. The overall differences in properties of [Glu304]MCADH together with its impaired folding and tetramer assembly may contribute to the generation of the abnormalities observed in patients homozygous for the K304E mutation.Keywords
This publication has 47 references indexed in Scilit:
- Effect of transition-state analogs on the redox properties of medium-chain acyl-CoA dehydrogenaseBiochemistry, 1995
- Characterization of Wild-Type Human Medium-Chain Acyl-CoA Dehydrogenase (MCAD) and Mutant Enzymes Present in MCAD-Deficient Patients by Two-Dimensional Gel Electrophoresis: Evidence for Posttranslational Modification of the EnzymeBiochemical Medicine and Metabolic Biology, 1994
- Co-overexpression of bacterial GroESL chaperonins partly overcomes non-productive folding and tetramer assembly of E. coli-expressed human medium-chain acyl-CoA dehydrogenase (MCAD) carrying the prevalent disease-causing K304E mutationBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1993
- Expression of wild-type and mutant medium-chain acyl-CoA dehydrogenase (MCAD) cDNA in eucaryotic cellsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1992
- Identification of a common mutation in patients with medium-chain acyl-CoA dehydrogenase deficiencyBiochemical and Biophysical Research Communications, 1990
- Green enzymes and suicide substrates: a look at the acyl-CoA dehydrogenases in fatty acid oxidationTrends in Biochemical Sciences, 1989
- Medium-chain acyl coenzyme A dehydrogenase from pig kidney has intrinsic enoyl coenzyme A hydratase activityBiochemistry, 1986
- Interflavin oxidation-reduction reactions between pig kidney general acyl-CoA dehydrogenase and electron-transferring flavoproteinBiochemistry, 1985
- Structure-function correlation of fatty acyl-CoA dehydrogenase and fatty acyl-CoA oxidaseBiochemistry, 1985
- Fluorometric assay of acyl-CoA dehydrogenases in normal and mutant human fibroblastsBiochemical Medicine, 1985